49536 Federal Register / Vol. 62, No. 183 / Monday, September 22, 1997 / Notices

ongoing Procurement Initiatives, some

of which include the following:

Consolidated Contracting Initiative

The CCI initiative emphasizes

developing, using, and sharing contract

resources to meet Agency objectives.

Single Process Intiative/Block Changes

The purpose of the Single Process

Initiative/Block changes is to eliminate

duplicative, highly-tailored or customerunique requirements from contacts and

adopt instead, a single process proposed

by the contractor.

Contractor Performance Assessment

Program

The Contractor Performance

Assessment Program assesses the overall

performance of NASA’s top contractors

across all of their major NASA

contracts.

Performance Based Contracting

This initiative is focused on

structuring an acquisition around the

purpose of the work to be performed

instead of how the work is to be

performed or broad and imprecise

statements of work.

Electronic Contracting

NASA’s EC initiative is moving

procurement transactions from

traditional paper-based systems to

electronic processing whenever

possible. These transactions include

solicitation and award documents as

well as payment for our goods and

services.

Tom Luedtke,

Deputy Associate Administrator for

Procurement.

[FR Doc. 97–25100 Filed 9–19–97; 8:45 am]

BILLING CODE 7510–01–M

NATIONAL FOUNDATION ON THE

ARTS AND HUMANITIES

SES Performance Review Board

AGENCY: National Endowment for the

Arts.

ACTION: Notice.

SUMMARY: Notice is hereby given of the

names of members of the Performance

Review Board for the National

Endowment for the Arts. This notice

supersedes all previous notices of the

PRB membership of the Agency.

DATES: September 22, 1997.

FOR FURTHER INFORMATION CONTACT:

Maxine C. Jefferson, Director of Human

Resources, National Endowment for the

Arts, 1100 Pennsylvania Avenue, N.W.,

Room 627, Washington, DC 20506, (202)

682–5405.

SUPPLEMENTARY INFORMATION: Sec.

4314(c)(1) through (5) of Title 5, USC,

requires each agency to establish, in

accordance with regulations prescribed

by the Office of Personnel Management,

one or more SES Performance Review

Boards. The Board shall review and

evaluate the initial appraisal of a senior

executive’s performance by the

supervisor, along with any response by

the senior executive, and make

recommendations to the appointing

authority relative to the performance of

the senior executive.

The following persons have been

selected to serve on the Performance

Review Board of the National

Endowment for the Arts:

Ana M. Steele, Deputy Chairman for

Management and Budget

Laurence M. Baden, Director of

Administration

Scott Shanklin Peterson, Deputy

Chairman for Grants and Partnership

Alfred B. Spellman, Jr., Director of

Office of Guidelines and Panel

Operations

Maxine C. Jefferson,

Director of Human Resources, National

Endowment for the Arts.

[FR Doc. 97–25062 Filed 9–19–97; 8:45 am]

BILLING CODE 7536–01–M

NUCLEAR REGULATORY

COMMISSION

[IA 97–070]

In the Matter of Magdy Elamir, Newark,

New Jersey; Order Superseding Order

Prohibiting Involvement in NRCLicensed Activities (Effective

Immediately)

I

Magdy Elamir, M.D. (Dr. Elamir), is

the Owner/President of Newark Medical

Associates, P.A. (licensee). The licensee

holds Byproduct Nuclear Material

License No. 29–30282–01 (license)

issued by the Nuclear Regulatory

Commission (NRC or Commission)

pursuant to 10 CFR Part 30. The license

authorizes possession and use of any

radiopharmaceutical identified in 10

CFR 35.200 for any imaging and

localization procedure approved in 10

CFR 35.200. The license was originally

issued on September 25, 1996, and is

due to expire on September 30, 2001.

II

During a new license inspection

conducted on January 29, 1997, at the

licensee’s facility, several apparent

violations of NRC requirements were

identified. Subsequent to the inspection,

the NRC initiated an investigation

which led the NRC to issue to Dr.

Elamir, on July 31, 1997, an Order

Prohibiting Involvement in NRC

Licensed Activities (Effective

Immediately) Pending Further Order (62

FR 43360). That Order was issued

pending completion of the NRC staff

review of the results of the

investigation, which was conducted by

the NRC’s Office of Investigations (OI).

The NRC staff’s review of the results of

the OI investigation is now complete.

III

The OI investigation focused, in part,

on Dr. Elamir’s actions in causing the

licensee to be in violation of NRC

requirements. The NRC learned during

the investigation that Dr. Elamir

transmitted an inaccurate license

application (NRC Form 313, dated

February 21, 1996) to the NRC. The

license application named Newark

Medical Associates as the prospective

licensee. The license application was

inaccurate in that it named Gerard W.

Moskowitz, M.D. (Dr. Moskowitz), as

the only authorized user and Radiation

Safety Officer (RSO) without Dr.

Moskowitz’s consent or knowledge, and

without Dr. Moskowitz’s ever having

been affiliated or associated with the

licensee. Dr. Moskowitz did not ever

perform the role of authorized user or

RSO at the licensee’s facility, and did

not become aware that he was listed on

the application and the license until

notified by the NRC on February 6,

1997, more than four months after the

license was originally issued. These

inaccurate statements in the license

application submitted by Dr. Elamir,

formed, in part, the basis for the

issuance of the license to Newark

Medical Associates on September 25,

1996.

On October 17, 1996, Dr Elamir

notified the NRC by letter that Newark

Medical Associates was initiating

activities authorized by the license; and

during the period from November 1996

through February 6, 1997, Dr. Elamir, in

his capacity as president and owner of

Newark Medical Associates, caused and

permitted the licensee to conduct NRClicensed activities even though he knew

that the licensee did not employ the

authorized user or the RSO named in

the license application and,

subsequently, on the NRC license, and

that the named individual did not serve

in these capacities. Based on the results

of the OI investigation, the NRC has

determined that Dr. Elamir’s actions

constitute violations of the

Commission’s requirements as follows:

A. 10 CFR 30.10(a)(2) requires, in

part, that any licensee or employee of a

licensee may not deliberately submit to